Is the vaccine-autism debate reopening? Washington Post sparks controversy with preemptive hit piece on David Geier
![]() |
(NaturalNews) David Geier, a researcher with expertise in thimerosal and vaccine-related data, has been tapped by the U.S. Department of Health and Human… |